title: [HIV infection: a chronic disease with new challenges].
abstract: The treatment of cardiovascular, metabolic and malignant diseases is playing an increasing role in HIV-infected patients. Intensified cancer screening is recommended, but data demonstrating a reduction of tumour incidence or tumour-associated mortality are rare. Controversy exists about the best time point of initiation of antiretroviral therapy. Recently, data indicate that an earlier start could reduce HIV transmission.
authors.affiliation: Klinik I für Innere Medizin, Uniklinik Köln, Kerpener Str. 62, 50937 Köln. norma.jung@uni-koeln.de
authors.forename: N
authors.initials: N
authors.lastname: Jung
authors.forename: J
authors.initials: J
authors.lastname: Fischer
authors.forename: C
authors.initials: C
authors.lastname: Lehmann
authors.forename: J K
authors.initials: JK
authors.lastname: Rockstroh
authors.forename: G
authors.initials: G
authors.lastname: Fätkenheuer
mesh_terms: D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000401:mortality; D002423:Cause of Death; D015897:Comorbidity; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis / Q000401:mortality; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D015996:Survival Rate
chemical_list: D019380:Anti-HIV Agents